Learn more about DUPIXENT® (dupilumab), a prescription medicine FDA-approved to treat six conditions. See how DUPIXENT® may help. Serious side effects can occur. Please see Important Safety Information and Prescribing Information and Patient Information on website.

DUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be used with or without topical corticosteroids.

Find videos and downloadable instructions for the two injection administration options available for DUPIXENT® (dupilumab), pre-filled syringe (200 mg or 300 mg) with needle shield for ages 6 months & older, or pre-filled pen (200 mg or 300 mg) for ages 2+ years.

Learn about DUPIXENT® (dupilumab) for moderate-to-severe asthma treatment. DUPIXENT® is a prescription medicine used as an add-on maintenance treatment for uncontrolled moderate-to-severe eosinophilic or oral steroid dependent asthma in people aged 6 years and older. Serious side effects can occur.

Find information on insurance coverage, ordering through a specialty pharmacy, and the cost of DUPIXENT® (dupilumab), a prescription medicine FDA-approved to treat six conditions. Serious side effects can occur. Please see Important Safety Information and Prescribing Information and Patient Information on website.

DUPIXENT MyWay® is a patient support program that may help eligible patients start and stay on track with DUPIXENT® (dupilumab) by providing tools, resources, and education throughout their treatment journey.

Find answers to frequently asked questions about DUPIXENT® (dupilumab), a prescription medicine FDA-approved to treat six conditions. Including how to administer DUPIXENT®, common side effects, and results seen in DUPIXENT® clinical trials. Serious side effects can occur. Please see Important Safety Information and Patient Information on ...

Learn more about DUPIXENT® (dupilumab), the first and only FDA-approved biologic treatment for adults with inadequately controlled COPD (chronic obstructive pulmonary disease) and a high number of blood eosinophils.

Learn more about DUPIXENT® (dupilumab), the first FDA-approved biologic to treat eosinophilic esophagitis (EoE) in adult and pediatric patients aged 1 year and older who weigh at least 33lb (15kg). Serious side effects can occur.

Learn how DUPIXENT can help you stay one step ahead of your uncontrolled moderate-to-severe eczema (atopic dermatitis).